Arcus Biosciences (RCUS) Cash from Financing Activities (2017 - 2026)
Arcus Biosciences (RCUS) posted Cash from Financing Activities of $16 million for Q2 2026, down 69.2% from $52 million a year earlier but up 433.3% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Cash from Financing Activities (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Arcus Biosciences was $313 million, up 30.4% year-over-year; for FY2025, it was $488 million, up 76.2% from FY2024.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
- In prior years, Arcus Biosciences' Cash from Financing Activities was $277 million in FY2024 (+739.4%), $33 million in FY2023 (unchanged), $33 million in FY2022 (-86.1%) and $237 million in FY2021 (-46.0%).
- Quarterly Cash from Financing Activities has run from a low of -$2 million in Q4 2024 to a high of $286 million in Q4 2025 over five years.
- On a year-over-year basis, Cash from Financing Activities increased in 1 of the last five quarters, with growth averaging 82.3%.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q3 2024, with growth of 700.0%; the weakest was Q3 2021, with a decline of 98.8%.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $3 million (Q1 2026), $286 million (Q4 2025) and $8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Arcus Biosciences | 3.28 Bn | -53.05 Mn | - | 16.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 286.00 Mn |
| Sep 30, 2025 | 8.00 Mn |
| Jun 30, 2025 | 52.00 Mn |
| Mar 31, 2025 | 142.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | 48.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 229.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 6.00 Mn |
| Jun 30, 2023 | 23.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 11.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 15.00 Mn |
| Dec 31, 2021 | 11.33 Mn |
| Sep 30, 2021 | 1.32 Mn |
API Access
Arcus Biosciences Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();